Meet ViroGates Management Team
Jakob Knudsen
Chief Executive Officer
Jakob assumed his role as CEO in April 2011.
Education
Master of Law, Copenhagen University
MBA from Imperial College, UK
Competencies
Working 25 years in life science, his extensive experience spans commercial operations, IP, sales and marketing, finance, partnerships, licensing, financing, listing requirements, a.o. Jakob Knudsen has held managerial positions in Egalet Corp. (CCO & CFO) and ALK-Abelló A/S (Head of Business Development).
Directorships
• Expres2ion Biotech Holding AB (BM)
• P.V. Fonden (BM)
• Jakob Knudsen (M)
• ExpreS2ion Biotechnologies ApS
• Ingeniørsystem A/S
Shareholdings as of 31 December 2023 incl. 2023 rights issue
- Shares: 125,514
- Warrants: 56,439 awarded, 13,253 exercised, 43,186 vested (unexercised)
Josephine Baum Jørgensen
Chief Financial Officer
Josephine assumed her role as CFO in March 2023
Education
Master of Science in Economics and Business Administration, Copenhagen Business School
Competencies
With more than five years in Deloitte’s management consulting department, Josephine has a solid background within project management, strategy, process optimization, and finance. More recently, she has held positions at the Ministry of Finance (as chief consultant) and in ATP (as manager of a large holiday fund).
Directorships
• None
Shareholdings as of 31 December 2023, incl. 2023 rights issue
- Shares: 1,200
- Warrants: 30,000 awarded, 0 exercised, 4,500 vested (unexercised)
Thomas Krarup
VP Global Sales & Marketing
Thomas joined ViroGates in March 2018.
Education
PhD in cell biology from Copenhagen University and Syracuse University, USA
CBA from AVT Business School
Competencies
Has worked in the life science and clinical diagnostics industry since 1997, holding positions within scientific marketing, licensing, business development and sales in Radiometer Medical A/S, Becton Dickinson, Roche Diagnostics, Oncotech Inc, Exiqon A/S and ChemoMetec A/S.
Directorships
• None
Shareholdings as of 31 December 2023, incl. 2023 rights issue
- Shares: 16,116
- Warrants: 20,209 awarded, 10,102 exercised, 10,107 vested (unexercised)
Jesper Eugen-Olsen
Chief Scientific Officer
Jesper founded the company with Jørgen Thorball and Peter Benson.
Education
PhD in Biochemistry, Copenhagen University.
Competencies
More than 30 years of research experience, author/co-author of +200 peer reviewed
scientific publications and 12 patents with two further patents pending. Further to being CSO at ViroGates, he is an independent expert and evaluator for a range of EU financed projects.
Directorships
• JEO Holding ApS (M)
Shareholdings as of as of 31 December 2023, incl. 2023 rights issue
- Shares: 260,976
- Warrants: 8,084 awarded, 5,051 exercised, 3,033 vested (unexercised)
